|
英国HTK研究 |
欧洲HTK研究 |
||
---|---|---|---|---|
肾脏存活率: |
HTK(n=314) |
UW(n=297) |
HTK(n=292) |
EC(n=277) |
1 year |
83% |
81% |
80% |
78% |
2 years |
77% |
73% |
76% |
71% |
3 years |
73% |
68% |
70% |
68% |
INF |
33% |
33% |
29% |
43% |
n=移植数量
INF=初始无功能,被定义为缺乏维持生命的肾功能,在移植后第一周需要两次或两次以上透析治疗
1) de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, Doxiadis II, Persijn GG. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int. 1999;12(6):447-53
急性肾损伤 |
CUSTODIOL(n=42) |
Ringer's group(n=42) |
---|---|---|
No AKI |
38.1% |
9.5% |
AKI type1 |
35.7% |
50.0% |
AKI type2 |
9.5% |
21.4% |
AKI type 3 |
16.7% |
19.0% |
急性肾损伤(AKI)由改善全球肾脏病预后组织指南定义。虽然CUSTODIOL组肾缺血时间相对较长(51.5分钟 vs 43.6分钟),但与冷乳酸林格液治疗组相比,CUSTODIOL 组可显著免于AKI。此外,CUSTODIOL不需要添加任何渗透剂和强的松。
2) Tshomba Y, Kahlberg A, Melissano G, Coppi G, Marone E, Ferrari D, Lembo R, Chiesa R. Comparison of renal perfusion solutions during thoracoabdominal aortic aneurysm repair.